20/20 Biolabs Inc: Maxim Group cuts target price to $2 from $5
AIDX•Maxim Group cut its target price for 20/20 Biolabs Inc to $2 from $5.
Related News
GordonMD Global Investments reports $16 million Pyxis Oncology common share purchase
PYXS•
Trump says US deal with South Korea includes $8.4 billion for oil recovery
USO•
Brazil's industrial output falls 0.6% in August
EWZ•
Rivian deliveries hit record high as R2 rollout gains momentum
RIVN•
AC Immune holds extraordinary general meeting
ACIU•